Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list ...

The FTC sued pharmacy benefit managers over their roles in increasing insulin prices over the past decade. The News talked to ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

All of this sounds fantastic and could make Lilly an excellent buy, but before you take action, consider this warning: This ...

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...

The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of ...

It may be time to add Covid-19 infection to the list of possible risk factors for developing type 2 diabetes at a young age.